Search results

Selected filters:

Law & Policy
North America

Article type

Topic

Sector

Jurisdictions

537 results found for your search

Sort options
14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC

13 August 2019

CAFC closes off another defence against <em>inter partes </em>review

IPR cancellations of pre-AIA rights are not unconstitutional takings under Fifth Amendment, Federal Circuit rules

09 August 2019

Chinese radio firm recently hit by ITC ruling is latest Trump target

Shenzhen-based Hytera, which makes two-way radios, joins Huawei on proposed list of banned government suppliers. It is already dealing with an ITC import ban won by rival Motorola Solutions

06 August 2019

Canadian IP initiative aims to kick-start a revolution

Although it is home to many big ticket patent players, Canada has lagged in encouraging SMEs to maximise the value of the rights they own; new programme designed to reverse that trend

05 August 2019

CAFC creates blueprint for early stage challenges to claims brought under doctrine of equivalents

Amgen’s infringement suit was barred by prosecution history estoppel as the Federal Circuit affirmed district court’s Rule 12(b)(6) dismissal

26 July 2019

Australian diagnostic method judgment shows US to be the eligibility outlier

Federal court’s detailed decision emphatically upholds patentability and emphasises, once again, that the Mayo regime is the exception not the rule

25 July 2019

Rubio’s new Huawei proposal is more nuanced, but should still worry US patent owners

The measure would not stop the company from enforcing patents outright, but it would severely hamper buying and selling activity

23 July 2019

It's security, stupid - why it's time to see the wood from the trees in the FTC's case against Qualcomm

If the US chipmaker’s recent court defeat stands then the US risks ceding to China a central role in the development of 5G and future wireless technology

15 July 2019

Huawei escalates patent fight with US defence company in new district court suit

Latest case against L3 Harris Technologies shows that the Chinese tech giant is prepared to leverage its IP rights amidst increasingly tense geopolitical climate

13 July 2019

<em>New York Times</em>’ seizure call shows how far the tide is turning against pharma IP

The newspaper’s controversial proposal is stark demonstration of the mounting patent pressure the life sciences sector is under in the US

11 July 2019

China’s venture community knows patents don’t equal innovation

The CEO of a hot AI startup, a top China-focused VC and Lenovo’s CIO shared their views on patents, innovation and trade tensions at one of Asia’s largest tech events

11 July 2019

New analysis shows impact that “blockbuster” decisions are having on patent litigation

RPX data highlights big drop in success of early 101 challenges in district court cases; if trend continues would point to shift in balance of power back to IP owners

11 July 2019

CAFC says Congress or SCOTUS must address diagnostics patentability controversy

Decision denying en banc rehearing of much-watched Athena case means that hopes for 101 reform now hinge on legislators and the Supreme Court

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

09 July 2019

Incorrectly naming an RPI will not derail an IPR, Federal Circuit rules

In Mayne Pharma, the court upheld a PTAB final written decision invalidating a patent despite the owner’s objection that all real-parties-in-interest were not properly named in the original review petition